News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



COVID-19 concerns force U.N. to prepare tsunami-hit Tonga relief aid at a distance

By Michelle Nichols and Praveen Menon (Reuters) - The United Nations is preparing for distanced relief operations in Tonga to avoid a COVID-19 outbreak in the Pacific island nation that is reeling

Stem cell-derived pancreatic cells may be alternative to islet transplants

By Marilynn Larkin NEW YORK (Reuters Health) - An ongoing first-in-human trial suggests that pancreatic cells grown from stem cells can be safely implanted into patients with type 1 diabetes, and in

Speech analysis can link voice changes to heart failure status

By Lisa Rapaport (Reuters Health) - Automated speech analysis software may be able to help identify patients with acute decompensated heart failure who are experiencing decompensation, a small study

PandAcuity test useful supplement to clinical visual-acuity tests in kids

By Lorraine L. Janeczko NEW YORK (Reuters Health) - A new test based on the so-called panda illusion can help doctors test visual acuity (VA) in children who are young or have developmental or

Zinc may worsen rheumatoid arthritis, lab study suggests

By Marilynn Larkin NEW YORK (Reuters Health) - Zinc supplementation may exacerbate rheumatoid arthritis (RA), new laboratory data suggest. In monocytes from patients with RA, researchers found high

Death, kidney injury rates in ICU patients similar with saline, multielectrolyte solution

By Gene Emery (Reuters Health) - A balanced multielectrolyte solution prevents death or acute kidney injury no better than standard saline when given to critically ill patients, a large study

Gilead says counterfeiting network sold $250 mln worth of its HIV drugs

By Reuters Staff (Reuters) - Gilead Sciences Inc said on Tuesday that tampered and counterfeit versions of its HIV treatments worth $250 million were sold to pharmacies over two years by a network of

EXCLUSIVE-Britain preparing for end-June switch to paid COVID tests -document

By Elizabeth Piper and Alistair Smout LONDON (Reuters) - British health officials are aiming to be ready to start charging Britons for COVID-19 tests that are currently free at the end of June, a

WHO says no evidence healthy children, adolescents need COVID-19 boosters

By Reuters Staff (Reuters) - There is no evidence at present that healthy children and adolescents need booster doses of COVID-19 vaccine, the World Health Organization's chief scientist Soumya

Lung-cancer screening leads to overdiagnosis among nonsmoking Asian women

By Megan Brooks NEW YORK (Reuters Health) - Expanding low-dose computed tomography (LDCT) screening for lung cancer to nonsmoking populations will likely lead to overdiagnosis of lung cancer, a study

EU watchdog urges vaccine developers not to focus only on Omicron

By Ludwig Burger and Pushkala Aripaka (Reuters) - The European Union drugs regulator said pharmaceuticals companies should work on more than one upgraded COVID-19 shot, not only tailored to the

Kids with pneumonia who respond to five days of antibiotics probably don't need more

By Megan Brooks NEW YORK (Reuters Health) - Children with community-acquired pneumonia (CAP) who respond to five days of antibiotic therapy can probably safely forego another five days of treatment,

EU regulator finds mRNA COVID-19 shots safe during pregnancy

By Reuters Staff (Reuters) - COVID-19 vaccines made using mRNA technology do not cause pregnancy complications for expectant mothers and their babies, the European Union's drug regulator said on

Gastrointestinal PCR panel enables faster, better antibiotic therapy in kids with infectious diarrhea

By Brandon May NEW YORK (Reuters Health) - Using a multiplex gastrointestinal PCR (GI-PCR) panel in children with infectious diarrhea can speed up appropriate prescription of antibiotics, a new study

China urges caution opening overseas mail after Omicron case

By Josh Horwitz SHANGHAI (Reuters) - China is urging people to wear masks and gloves when opening mail, especially from abroad, after authorities suggested the first case of the Omicron coronavirus

Australia suffers deadliest day of pandemic as Omicron drives up hospital cases

By Renju Jose SYDNEY (Reuters) - Australia suffered its deadliest day of the pandemic on Tuesday as a fast-moving Omicron outbreak continued to push up hospitalisation rates to record levels, even as

Israel sticks with 4th vaccine shot, sees Omicron wave waning next week

By Dan Williams JERUSALEM (Reuters) - Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is not enough to prevent Omicron infections, the Health Ministry

Healthy lifestyle interventions may be best started in preschool

By Linda Carroll (Reuters Health) - Implementing school-based programs aimed at teaching healthy cardiovascular habits starting in preschool can achieve lasting lifestyle changes in children,

Canada approves Pfizer's oral COVID-19 antiviral treatment, seeks supplies

By David Ljunggren and Ismail Shakil OTTAWA (Reuters) - Canada on Monday approved Pfizer Inc's oral antiviral treatment for mild to moderate cases of COVID-19 in people aged 18 and older but said

Secondhand vaping linked with respiratory symptoms in young adults

By Linda Carroll (Reuters Health) - Exposure to secondhand vape at home may be linked to a heightened risk for respiratory symptoms in young adults, a new study suggests. An analysis of data from

Pathological complete response likely not a reliable survival surrogate in early breast cancer

By Marilynn Larkin NEW YORK (Reuters Health) - A new meta-analysis suggests that pathological complete response (pCR) should not be used as a surrogate endpoint in randomized trials of neoadjuvant

Vaccine-like mRNA injection effectively treats cardiac fibrosis in mice

By Marilynn Larkin NEW YORK (Reuters Health) - A vaccine-like injection of modified mRNA temporarily reprogrammed immune cells to attack fibroblasts in a mouse model of heart failure, resulting in "

Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron

By Ari Rabinovitch JERUSALEM (Reuters) - A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to a

South African hospital saw less serious disease with Omicron

By Reuters Staff (Reuters) - Doctors in one of the cities where Omicron was first identified say the surge driven by the new variant has been marked by less serious disease than earlier waves of the

Unique strings of molecules may predict variants' success

By Reuters Staff (Reuters) - Researchers believe they have discovered an important way to identify SARS-CoV-2 variants that are likely to spread. Looking at 9-unit strings of nucleotides - the

Lower COVID-19 risks seen after weight-loss surgery

By Reuters Staff (Reuters) - Weight-loss surgery may reduce the risk of severe COVID-19 even if the infected person is still obese after losing weight, according to a report in JAMA Surgery.

Risankizumab effective against refractory psoriatic arthritis

By Matthew Phelan NEW YORK (Reuters Health) - Risankizumab, an inhibitor of interleukin 23, provides some relief for patients with active psoriatic arthritis (PsA) whose symptoms have responded poorly

Good long-term outcomes of kidney/liver transplant in adults with HIV

By Reuters Staff NEW YORK (Reuters Health) - HIV-positive kidney- and liver-transplant patients can expect good long-term outcomes following the transplant, comparable with those of matched

India's Gennova developing Omicron-specific COVID-19 vaccine

By Krishna N. Das NEW DELHI (Reuters) - India's Gennova Biopharmaceuticals is working on an Omicron-specific mRNA COVID-19 vaccine candidate, it told Reuters on Monday, after a person with direct

Moderna CEO says data for Omicron-specific shot likely available in March

By Reuters Staff (Reuters) - Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share

Germany one step closer to scrapping Nazi-era abortion law

By Reuters Staff BERLIN (Reuters) - Germany's justice ministry presented a draft law on Monday that would do away with a Nazi-era law forbidding doctors to provide information about abortions. Doctors

Schizophrenia tied to increased risk of violence perpetration

By Lisa Rapaport (Reuters Health) - Individuals with schizophrenia spectrum disorders are more likely to perpetrate violence than their counterparts without these conditions, a systematic review and

Experimental drug targets COVID-19 from two angles

By Reuters Staff (Reuters) - An experimental drug originally being developed to treat influenza is showing promise against SARS-CoV-2 and might defend against COVID-19 from two different directions,

Vapers risk more symptoms from COVID-19

By Reuters Staff (Reuters) - E-cigarette users infected with the coronavirus may be more likely than infected non-vapers to experience COVID-19 symptoms, according to research published in the Journal

Many people could still be infectious after 5-day quarantine

By Reuters Staff (Reuters) - After a five-day quarantine, about a third of people infected with SARS-CoV-2 might still be infectious, according to new data. PCR tests detect virus particles but cannot

U.S. judge bars Martin Shkreli from drug industry, orders $64.6 mln payment

By Diane Bartz and Jonathan Stempel WASHINGTON (Reuters) - A U.S. judge on Friday barred Martin Shkreli from the pharmaceutical industry for life and ordered him to pay $64.6 million after he famously

UPDATE 1-U.S. suicide hotline 988 is set to go live, but many states may not be ready

(Adds Lifeline calls in Washington and Wyoming, paragraph 10) By Barbara Goldberg NEW YORK (Reuters) - In just six months, 988 goes live as the shortcut to call or text the U.S. suicide hotline at a

COLUMN-A quiet experiment is testing broader privatization of U.S. Medicare

(The opinions expressed here are those of the author, a columnist for Reuters.) By Mark Miller (Reuters) - Millions of retirees have opted out of traditional Medicare over the past two decades,

FDA approves expanded use of AbbVie's arthritis drug to treat eczema

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration approved the expanded use of AbbVie Inc's arthritis drug to treat eczema, a skin disease, the company said on Friday. The approval of

Humoral response to SARS-CoV-2 infection only slightly lower in liver-transplant patients

By Reuters Staff NEW YORK (Reuters Health) - The humoral response to SARS-CoV-2 infection among liver transplant (LT) recipients is only slightly lower than expected, researchers in the Netherlands

EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot

By Reuters Staff (Reuters) - A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19

J&J booster 85% effective against Omicron hospitalisation, S.Africa says

By Tim Cocks JOHANNESBURG (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is

EU excess deaths in November hit highest in a year - Eurostat

By Reuters Staff (Reuters) - Around 27% more people died in the European Union than usual during November, the biggest increase in a year as a fresh wave of COVID-19 swept the region, official data

Omicron has 1/3 reduced risk of hospitalisation compared to Delta - UK researchers

By Reuters Staff LONDON (Reuters) - There is a one third reduction in the risk of going into hospital associated with the Omicron variant of COVID-19 compared with Delta, researchers at Imperial

S.African study suggests Omicron less severe even for unvaccinated

By Reuters Staff JOHANNESBURG (Reuters) - Unvaccinated people infected with the Omicron variant of coronavirus may be less prone to severe illness and requiring hospital care or dying than was the

U.S. suicide hotline 988 is set to go live, but many states may not be ready

By Barbara Goldberg NEW YORK (Reuters) - In just six months, 988 goes live as the shortcut to call or text the U.S. suicide hotline at a time when the pandemic is ramping up the need for mental health

Peak Omicron? Experts wary of calling time on variant wave in Europe

By Alistair Smout and Nikolaj Skydsgaard (Reuters) - A surge in coronavirus cases caused by the Omicron variant may have peaked in some parts of Europe but medics say the impact will continue to be

FOCUS-Burned by COVID supply crunch, hospitals invest in U.S. mask-making

By Lisa Baertlein (Reuters) - Two days before Christmas, a cargo ship left Mumbai with a mask-making machine bound for Illinois-based OSF HealthCare, which will use the equipment to make its own N95

Anemia in astronauts could be a challenge for space missions

By Harikrishnan Nair (Reuters) - The next "giant leap" for humans may be a trip to Mars, but having enough oxygen-carrying red blood cells for the journey might present a challenge, new research

Short list of smells may diagnose olfactory dysfunction in home test

By Linda Carroll NEW YORK (Reuters Health) - People who are concerned about loss of smell may be able to confirm that loss with a home test that includes the odors of as few as three common household

UK study finds more Omicron hospitalisations in youngest children, but cases mild

By Reuters Staff LONDON (Reuters) - Infants under 12 months of age are proportionally more likely to be hospitalised with the Omicron variant of the coronavirus than older children but they do not

Abdominopelvic surgery risks in pregnancy vary by gestational age, indication

By Reuters Staff NEW YORK (Reuters Health) - Abdominopelvic surgery for non-obstetric reasons is often necessary during pregnancy and the risk of harm to the fetus varies by gestational age,

Dexamethasone effective as an analgesic adjuvant in total knee replacement

By Megan Brooks NEW YORK (Reuters Health) - Two doses of dexamethasone given in the perioperative period reduced morphine consumption during 48 hours after total knee arthroplasty (TKA) and reduced

Transcatheter pulmonary-valve replacement, surgery appear to have comparable outcomes

By Reuters Staff NEW YORK (Reuters Health) - Patients who undergo transcatheter pulmonary-valve replacement (TPVR) face similar odds of surviving and not needing reintervention or surgery as those who

New tool helps predict severe pain during wound dressing changes

By Marilynn Larkin NEW YORK (Reuters Health) - A newly developed tool pinpointed three variables - type of dressing, expected pain and resting pain - that can be used to predict which patients are

Disparities in GLP-1 receptor agonist use in type 2 diabetes

By Lisa Rapaport (Reuters Health) - White and more affluent patients with type 2 diabetes are significantly more likely to receive glucagon-like peptide-1 (GLP-1) receptor agonist therapy than

Incident anorexia among youth increased during COVID-19 pandemic

By Lisa Rapaport (Reuters Health) - The incidence and severity of new-onset anorexia nervosa increased among children and adolescents during the COVID-19 pandemic, a Canadian study suggests.

Court suspends order to wear masks outdoor in Paris - AFP

By Reuters Staff PARIS (Reuters) - A French administrative tribunal on Thursday suspended an order that masks be worn on the streets of Paris, news agency AFP reported. The mask mandate, imposed by

U.S. Supreme Court blocks Biden vaccine-or-test policy for large businesses

By Lawrence Hurley and Andrew Chung WASHINGTON (Reuters) - The U.S. Supreme Court on Thursday blocked President Joe Biden's pandemic-related vaccination-or-testing mandate for large businesses at a

UPDATE 2-U.S. to send 1,000 military health workers, free masks to fight COVID-19

(Adds comments from Biden, details, context) By Susan Heavey WASHINGTON (Reuters) - President Joe Biden on Thursday said he will deploy more military health workers to six U.S. states beginning next

EU court rejects cities' bid to curb car emissions

By Reuters Staff BRUSSELS (Reuters) - The European Union's top court dismissed a complaint on Thursday brought by the cities of Brussels, Madrid and Paris against the European Commission in which they

Biogen seeks dialogue with U.S. CMS about Alzheimer's drug coverage decision

By Manojna Maddipatla (Reuters) - Biogen Inc's chief executive officer on Thursday said the company wants a dialogue with the U.S. Centers for Medicaid and Medicare Services (CMS) ahead of a final

UPDATE 1-U.S. sending 1,000 military health workers to U.S. COVID-19 hot spots

(Updates with news of 500 million more tests) By Susan Heavey WASHINGTON (Reuters) - Another 1,000 military health workers are deploying to six U.S. states beginning next week to help hospitals

S.Africa still seeing serious COVID-19 in unvaccinated, vulnerable during Omicron wave

By Reuters Staff JOHANNESBURG (Reuters) - A South African pulmonologist said on Thursday that she was still seeing serious COVID-19 disease in people who are unvaccinated or have comorbidities during

COVID-19 patients with greatest odds of surviving should get first dibs on scarce ICU beds: survey

By Linda Carroll NEW YORK (Reuters Health) - A new survey finds most Americans are in favor of allotting "the last ICU bed" to the patient with the highest probability of surviving COVID-19. Responses

New data support lowering screening age to 45 for colorectal cancer

By Reuters Staff NEW YORK (Reuters Health) - A new study confirms an increasing incidence of young-onset precancerous colorectal neoplasia among adults younger than age 50 and supports updated

Abiraterone therapy tied to longer survival in Black vs. white men with metastatic castration-resistant prostate cancer

By Lorraine L. Janeczko NEW YORK (Reuters Health) - African American men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone survive longer than their non-Hispanic

Among those under 50, sex rarely leads to sudden cardiac death

By Linda Carroll NEW YORK (Reuters Health) - Sudden cardiac death in those under 50 is rarely associated with sexual activity, a new study finds. An analysis of data from nearly 7,000 cases of sudden

Diverse needs of post-COVID-19 patients managed in or out of the hospital

By Megan Brooks NEW YORK (Reuters Health) - A large study from the UK shows that patients who recover from COVID-19, whether managed in or outside the hospital, often seek care from their primary-care

England's colourful deputy chief medical officer to step down

By Reuters Staff LONDON (Reuters) - England's deputy chief medical officer Jonathan Van-Tam, whose use of colourful metaphors and similes became a hallmark of the British government's COVID-19 news

Poorer nations dump millions of close-to-expiry COVID-19 vaccines - UNICEF

By Francesco Guarascio BRUSSELS (Reuters) - Poorer nations last month rejected more than 100 million doses of COVID-19 vaccines distributed by the global programme COVAX, mainly due to their rapid

AstraZeneca says early trial data indicates third dose helps against Omicron

By Pushkala Aripaka and Ludwig Burger (Reuters) - AstraZeneca said on Thursday that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in neutralising

More U.S. medical teams to bolster states as Omicron surges

By Reuters Staff WASHINGTON (Reuters) - Another 1,000 federal health workers are deploying to six states to help alleviate overwhelmed hospitals amid the U.S. surge in Omicron-related COVID-19 cases,

REFILE-Rates of fatal drug overdose rise during COVID-19 pandemic among men, at-home deaths

(Refiling October 26 story to correct formatting problem experienced by some clients.) By Lisa Rapaport (Reuters Health) - Rates of drug overdose fatalities climbed overall in Rhode Island over the

Long COVID "brain fog" shares features with "chemo brain"

By Reuters Staff (Reuters) - The "brain fog" reported by some people after COVID-19 shows striking similarities to the condition known as "chemo brain" - the mental cloudiness some people experience

Experimental clip-on device finds virus particles in air

By Reuters Staff (Reuters) - A small experimental device designed to be attached to clothing may be able to tell whether the wearer has been exposed to SARS-CoV-2 particles in the air, researchers

Researchers plan for reusing N95 respirator masks

By Reuters Staff (Reuters) - A type of mask used by healthcare providers to protect themselves from the coronavirus can be reprocessed to augment supplies, researchers believe. Unlike cloth and

Pfizer COVID vaccine highly effective at preventing hospitalization in adolescents in real-world study

By Reuters Staff (Reuters Health) - A large real-world study of the two-dose Pfizer COVID-19 vaccine has confirmed that it is highly effective at preventing hospitalizations, the need for intensive

Quebec tax on unvaccinated may be lawful but sets risky precedent - experts

By Anna Mehler Paperny and David Ljunggren TORONTO (Reuters) - A proposal by Quebec to tax unvaccinated people may be lawful but may also go against the spirit of Canada's universal public health

Nine-fold increase in carbon monoxide poisonings after power outages

By Gene Emery (Reuters Health) - A study of long-term power outages in the U.S. has confirmed the widespread suspicion that carbon monoxide emergencies spike after a power outage, and the increase

Pre-omicron study: Vaccines offer 8 months protection from COVID hospitalization

By Gene Emery (Reuters Health) - A North Carolina study of the waning effectiveness of the three COVID-19 vaccines given in the United States shows that although protection against illness from the

FDA flags risk of dental issues from use of opioid addiction drug buprenorphine

By Reuters Staff (Reuters) - The U.S. health regulator on Wednesday warned patients and prescribers about the risk of potential dental problems arising from the use of buprenorphine medicines to treat

Cannabis use associated with elevated cardiovascular disease risk

By Lisa Rapaport (Reuters Health) - Individuals who use cannabis have a higher risk of cardiovascular disease risk factors compared to counterparts who don't use the drug, a recent study suggests.

Omicron less severe than Delta but still poses danger for unvaccinated: WHO

By Reuters Staff (Reuters) - The highly infectious Omicron coronavirus variant causes less severe disease than the Delta strain but it remains a "dangerous virus", particularly for those who are

Medical Jobs

Search healthcare jobs by specialty or location.